Open AccessDevelopment of a novel 3-month drug releasing risperidone microspheres
Author(s) -
Bhanusree Yerragunta,
Satheesh Jogala,
Krishna Mohan Chinnala,
Jithan Aukunuru
Publication year - 2015
Publication title -
journal of pharmacy and bioallied sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 36
eISSN - 0976-4879
pISSN - 0975-7406
DOI - 10.4103/0975-7406.148777
Subject(s) - materials science , in vivo , polymer , drug , differential scanning calorimetry , microsphere , biomedical engineering , dosage form , chemical engineering , pharmacology , chromatography , nanotechnology , chemistry , composite material , medicine , microbiology and biotechnology , physics , engineering , biology , thermodynamics
The purpose of this study was to develop an ideal microsphere formulation of risperidone that would prolong the drug release for 3 months in vivo and avoid the need for co-administration of oral tablets.